Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Genomics. 2013 Dec;14(8):568-77. doi: 10.2174/1389202914666131210212521.

Pharmacogenetics of Parkinson's disease - through mechanisms of drug actions.

Author information

1
Department of Pharmacology, Pomeranian Medical University, Szczecin, Poland.

Abstract

In the last years due to development of molecular methods a substantial progress in understanding of genetic associations with drug effects in many clinical disciplines has been observed. The efforts to define the role of genetic polymorphisms in optimizing pharmacotherapy of Parkinson's disease (PD) were also undertaken. So far, some promising genetic loci for PD treatment were determined. In the review pharmacogenetic aspects of levodopa, dopamine agonists and COMT inhibitors are discussed.

KEYWORDS:

Genetic polymorphism.; Parkinson’s disease; Pharmacogenetics

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center